Upper Gastrointestinal Lesions in Crohn's Disease
1 other identifier
interventional
160
1 country
1
Brief Summary
A cross-sectional study was performed from 2017 to 2018. Consecutive Crohn's disease patients diagnosed in the Inflammatory bowel disease center of the Sixth Affiliated Hospital of Sun Yat-sen University were recruited. All patients underwent upper gastrointestinal endoscopy and biopsy by two defined endoscopists and two pathologists, the basic information were collected at the same time, in order to assess the prevalence of upper gastrointestinal involvement, and determine the role of upper gastrointestinal endoscopy in adult Crohn's disease patients, irrespective of upper gastrointestinal symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 30, 2018
CompletedFirst Posted
Study publicly available on registry
May 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2018
CompletedMay 14, 2018
May 1, 2018
12 months
April 30, 2018
May 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
the incidence of different upper gastrointestinal lesions
The incidence of different characteristic lesions of upper gastrointestinal in CD patients.
1 year
Study Arms (1)
adult patients with Crohn's disease
OTHERAll adult patients(18 years old or older) with Crohn's disease underwent gastroscopy; patients with diagnosed and treated Crohn's disease had gastroscopy performed during the re-examination, and patients diagnosed with Crohn's disease for the first time had gastroscopy performed during the initial consultation.
Interventions
Two endoscopists performed upper gastrointestinal endoscopy and biopsy on all patients; and histological review was performed by two pathologists. From each patient, 10 specimens were taken from 6 areas in the upper gastrointestinal tract and basic informations was collected.
Eligibility Criteria
You may qualify if:
- Age is 18 years old or older
- patients with diagnosis of Crohn's disease
You may not qualify if:
- diagnostic data were incomplete
- patients with malignant tumor
- use of PPIs or non-steroidal anti-inflammatory drugs in the preceding 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510655, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xiang Gao
Sixth Affiliated Hospital, Sun Yat-sen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
April 30, 2018
First Posted
May 14, 2018
Study Start
June 1, 2017
Primary Completion
May 30, 2018
Study Completion
May 30, 2018
Last Updated
May 14, 2018
Record last verified: 2018-05